Viva Biotech Holdings reports increase in issued shares for October

Viva Biotech Holdings reported a total increase of 1,448,048 in its issued ordinary shares (excluding treasury shares) for the month ended 31 October 2025. This brings the total number of issued shares to 2,129,882,353 as of month-end. The movement was primarily due to the exercise of options under the Pre-IPO Share Incentive Schemes, which saw 1,448,048 new shares issued.

The exercise of these share options generated total funds of $178,156.24 during the month. The number of share options outstanding under the Pre-IPO Share Incentive Schemes decreased to 2,217,093. The Post-IPO Share Options Scheme maintained 9,620,000 outstanding options, with no new shares issued or exercised during the period.

The company's authorized/registered share capital remained stable at 4,000,000,000 ordinary shares with a par value of $0.000025, totaling $100,000. There were no movements in treasury shares reported for the month.